Posts about

hemato-oncology

COVID-19 2nd Phase - Impact on Physicians’ Practice - Syndicated Study

hemato-oncology, COVID-19, Syndicated Studies, Oncology

How does COVID-19 affect the HCPS relationships with patients and with the pharmaceutical...

DLBCL Patient Insights in the US and EU5

hemato-oncology, DLBCL market

When working on a new or existing brand within the DLBCL market it's important to have up to...

DLBCL Treatment Performance in EU5 and US

hemato-oncology, Tracking Studies, DLBCL market

The DLBCL market is undergoing a period of change, and the relative performance of the various...

DLBCL Market Overview

hemato-oncology, Tracking Studies, DLBCL market

Following the release of our latest ebook, this is the first blog post in this series focusing...

New AplusA eBook Covers the DLBCL Market

AplusA News, hemato-oncology

Introducing the latest eBook in AplusA's Hemato-Oncology series

 

Patient Insights from AplusA’s Multiple Myeloma Tracker

hemato-oncology

A thoughtfully developed tracker can provide deep insights on any therapeutic area. Using the...

Multiple Myeloma Market Dynamics Revealed by AplusA Tracker

hemato-oncology

A thoughtfully developed tracker can provide deep insights on any therapeutic area. Using the...

Brand Performance Insights from AplusA's Multiple Myeloma Tracker

hemato-oncology

A thoughtfully developed tracker can provide deep insights on any therapeutic area. Using the...

Key Insights from a Multiple Myeloma Tracker

hemato-oncology

A thoughtfully developed tracker can provide deep insights on any therapeutic area. Using the...

Who Are The Key Hemato-Oncology Market Stakeholders?

Healthcare Industry, hemato-oncology

As a marketing professional in the healthcare industry, you need to accurately identify the...